| ZScore | RScore | Entity Type | ID | Name | Synonyms |
|---|---|---|---|---|---|
| 3.25920338447 | 60 - [0, 0, 2, 2] | Diseases | DID31595 | Diabetes Mellitus, Type II | Diabetes Mellitus, Type II; MODY; DIABETES, MATURITY ONSET; Diabetes Mellitus, Non Insulin Dependent; NIDDM - Non-insulin dependent diabetes mellitus; Diabetes Mellitus, Type 2; AODM; Type 2 diabetes mellitus; ketosis resistant diabetes; ADULT ONSET DIABETES MELLITUS; Non-insulin dependent diabetes mellitus; DIABETES MELLITUS, NON-INSULIN DEPENDENT; type II diabetes mellitus; Non-Insulin Dependent Diabetes; Adult-Onset Diabetes Mellitus; Non-Insulin-Dependent Diabetes Mellitus; noninsulin dependent diabetes mellitus; Stable Diabetes Mellitus; Maturity onset diabetes; DIABETES MELLITUS, TYPE II; NIDDM; Diabetes Mellitus, Non-Insulin-Dependent; Ketosis-Resistant Diabetes Mellitus; Maturity-Onset Diabetes Mellitus; Type II Diabetes; Diabetes mellitus type II; Maturity Onset Diabetes Mellitus; Diabetes mellitus type 2; Vasopressin-Sensitive Diabetes Insipidus; Maturity-onset diabetes of the young; Mason-type diabetes |
| RScore | Document | Snippets | Details |
|---|---|---|---|
| 30 - [0, 0, 1, 1] |
Novel insights of elevated systemic levels of bisphenol-A (BPA) linked to poor glycemic control, accelerated cellular senescence and insulin resistance in patients with type 2 diabetes. [MEDLINE : 31004310] |
(2019) Novel insights of elevated systemic levels of bisphenol-A (BPA) linked to poor glycemic control, accelerated cellular senescence and insulin resistance in patients with type 2 diabetes. Molecular and cellular biochemistry;Mol. Cell. Biochem.;2019 Aug;458(1-2):171-183 - There is a striking interaction of genes and environment in the etiology of type 2 diabetes mellitus (T2DM). - While endocrine disrupting chemicals (EDCs) like bisphenol-A (BPA) have received special attention for their mechanistic role in metabolic disruption, there is a lack of clinically relevant data on BPA levels in Asian Indians, a population which is more susceptible to type 2 diabetes mellitus (T2DM) and cardiovascular diseases. |
Details |
| 25 - [0, 0, 1, 0] |
Urinary concentrations of environmental phenols and their association with type 2 diabetes in a population in Jeddah, Saudi Arabia. [MEDLINE : 29960220] |
(2018) Urinary concentrations of environmental phenols and their association with type 2 diabetes in a population in Jeddah, Saudi Arabia. Environmental research;Environ. Res.;2018 10;166:544-552 - A few epidemiologic studies suggest that exposure to bisphenol A (BPA) is associated with type 2 diabetes mellitus (T2DM). |
Details |
| 5 - [0, 0, 0, 1] |
Biomonitoring of human exposures to chlorinated derivatives and structural analogs of bisphenol A. [MEDLINE : 26521216] |
(2015) Biomonitoring of human exposures to chlorinated derivatives and structural analogs of bisphenol A. Environment international;Environ Int;2015 Dec;85:352-79 - Up to date findings indicated the association of ClxBPA with metabolic conditions, such as obesity, lipid accumulation, and type 2 diabetes mellitus, particularly in in-vitro and in-vivo studies. |
Details |
Liu Y., Liang Y., Wishart D.S. (2015) PolySearch 2.0: A significantly improved text-mining system for discovering associations between human diseases, genes, drugs, metabolites, toxins, and more. Nucleic Acids Res. 2015 Jul 1;43(Web Server Issue):W535-42.
Cheng D., Knox C., Young N., Stothard P., Damaraju S., Wishart D.S. (2008) PolySearch: a web-based text mining system for extracting relationships between human diseases, genes, mutations, drugs and metabolites. Nucleic Acids Res. 2008 Jul 1;36(Web Server Issue):W399-405.
This project is supported by the Canadian Institutes of Health Research (award #111062), Alberta Innovates - Health Solutions, and by The Metabolomics Innovation Centre (TMIC), a nationally-funded research and core facility that supports a wide range of cutting-edge metabolomic studies. TMIC is funded by Genome Alberta, Genome British Columbia, and Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $900 million in funding from the federal government.